S.A. Harrison

860 total citations
25 papers, 639 citations indexed

About

S.A. Harrison is a scholar working on Epidemiology, Hepatology and Plant Science. According to data from OpenAlex, S.A. Harrison has authored 25 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Hepatology and 8 papers in Plant Science. Recurrent topics in S.A. Harrison's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (5 papers) and Wheat and Barley Genetics and Pathology (4 papers). S.A. Harrison is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis C virus research (5 papers) and Wheat and Barley Genetics and Pathology (4 papers). S.A. Harrison collaborates with scholars based in United States, United Kingdom and Germany. S.A. Harrison's co-authors include Christopher P. Day, Brent A. Neuschwander‐Tetri, Elizabeth M. Brunt, A DIBISCEGLIE, D.R. Oliver, Bruce R. Bacon, H. J. Mascagni, Dawn M. Torres, David A. Van Sanford and G. B. Padgett and has published in prestigious journals such as Hepatology, Gut and European Heart Journal.

In The Last Decade

S.A. Harrison

23 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.A. Harrison United States 13 319 259 169 127 70 25 639
Naoki Murayama Japan 11 357 1.1× 43 0.2× 354 2.1× 33 0.3× 25 0.4× 17 668
Eddison Godinez Leiva United States 6 260 0.8× 11 0.0× 108 0.6× 132 1.0× 34 0.5× 9 389
Xu You China 13 78 0.2× 162 0.6× 14 0.1× 39 0.3× 22 0.3× 41 574
Qing Gu China 13 252 0.8× 161 0.6× 79 0.5× 44 0.3× 15 0.2× 21 619
Guohui Li China 11 64 0.2× 92 0.4× 65 0.4× 15 0.1× 5 0.1× 41 380
Yanjie Lin China 9 109 0.3× 32 0.1× 75 0.4× 13 0.1× 20 0.3× 24 373
Khalid A. Osman United Kingdom 10 72 0.2× 135 0.5× 16 0.1× 18 0.1× 5 0.1× 23 339
Keke Dang China 10 134 0.4× 91 0.4× 4 0.0× 152 1.2× 96 1.4× 22 577
Xingxing Gao China 13 95 0.3× 131 0.5× 40 0.2× 5 0.0× 24 0.3× 28 556
José Mexico 8 43 0.1× 142 0.5× 27 0.2× 12 0.1× 28 0.4× 58 336

Countries citing papers authored by S.A. Harrison

Since Specialization
Citations

This map shows the geographic impact of S.A. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.A. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.A. Harrison more than expected).

Fields of papers citing papers by S.A. Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.A. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.A. Harrison. The network helps show where S.A. Harrison may publish in the future.

Co-authorship network of co-authors of S.A. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of S.A. Harrison. A scholar is included among the top collaborators of S.A. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.A. Harrison. S.A. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taub, Rebecca, Juan P. Frías, Seth J. Baum, S.L. Hsia, & S.A. Harrison. (2019). P1521In a 36-week placebo-controlled phase 2 trial in patients with non-alcoholic steatohepatitis (NASH), treatment with MGL-3196 (resmetirom) significantly reduces atherogenic lipoprotein particles. European Heart Journal. 40(Supplement_1). 1 indexed citations
2.
Harrison, S.A., H. Wilman, Matt Kelly, et al.. (2018). Prevalence and stratification of NAFLD/NASH in a UK and US cohort using non-invasive multiparametric MRI. Journal of Hepatology. 68. S550–S550. 1 indexed citations
4.
Francque, Sven, S.A. Harrison, A. Sanyal, et al.. (2016). Relationship between Baseline Hepatic Disease Severity and the Cardiometabolic and Anti-Inflammatory Effects of Elafibranor in Patients with Non-Alcoholic Steatohepatitis. Journal of Hepatology. 64(2). S499–S500. 1 indexed citations
6.
Khattab, Mahmoud, et al.. (2011). 1160 INSULIN RESISTANCE IN HEPATITIS C GENOTYPE 4 IS PARTIALLY MEDIATED BY VIRUS-SPECIFIC CHANGES IN ADIPOCYTOKINES. Journal of Hepatology. 54. S458–S458. 2 indexed citations
8.
Harrison, S.A., et al.. (2011). Do we need a histological score to diagnose non-alcoholic steatohepatitis? authors’ reply. Alimentary Pharmacology & Therapeutics. 34(4). 495–496.
9.
Mascagni, H. J., S.A. Harrison, & G. B. Padgett. (2008). Influence of Sulfur Fertility on Wheat Yield Performance on Alluvial and Upland Soils. Communications in Soil Science and Plant Analysis. 39(13-14). 2133–2145. 17 indexed citations
10.
Torres, Dawn M., et al.. (2008). Nonalcoholic fatty liver disease.. PubMed. 99(6). 583–93. 18 indexed citations
11.
Harrison, S.A. & Christopher P. Day. (2007). Benefits of lifestyle modification in NAFLD. Gut. 56(12). 1760–1769. 182 indexed citations
12.
Harrison, S.A., Elizabeth M. Brunt, D.R. Oliver, et al.. (2005). Effect of Significant Histologic Steatosis or Steatohepatitis on Response to Antiviral Therapy in Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 3(6). 604–609. 74 indexed citations
13.
Brechner, Ross J., et al.. (2005). A graded, evidence-based summary of evidence for bariatric surgery. Surgery for Obesity and Related Diseases. 1(4). 430–441. 9 indexed citations
14.
Harrison, S.A., Elizabeth M. Brunt, Zachary Goodman, & A DIBISCEGLIE. (2003). 230 Diabetic hepatosclerosis: perisinusoidal hepatic fibrosis without steatohepatitis among diabetics. Hepatology. 38. 266–267. 1 indexed citations
15.
Harrison, S.A., Elizabeth M. Brunt, D.R. Oliver, et al.. (2003). 977 The presence of severe steatosis or steatohepatitis impairs response to antiviral therapy in patients with chronic hepatitis C. Hepatology. 38. 626–626. 1 indexed citations
16.
Harrison, S.A., et al.. (2002). Losses in Wheat Due to Waterlogging. Crop Science. 42(2). 444–450. 106 indexed citations
17.
Harrison, S.A., et al.. (2002). Losses in Wheat Due to Waterlogging. Crop Science. 42(2). 444–444. 39 indexed citations
18.
Tillman, Barry L., et al.. (1998). Relationship Between Flag Leaf Symptoms Caused by Xanthomonas translucens pv. translucens and Subsequent Seed Transmission in Wheat. Plant Disease. 82(12). 1341–1344. 17 indexed citations
19.
Mascagni, H. J., et al.. (1997). Nitrogen and fungicide effects on winter wheat produced in the Louisiana Gulf Coast region. Journal of Plant Nutrition. 20(10). 1375–1390. 16 indexed citations
20.
Miller, Grady L., et al.. (1993). Forage and Grain Yields of Wheat and Triticale as Affected by Forage Management Practices. Crop Science. 33(5). 1070–1075. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026